SCHEMBL306852

SCHEMBL306852

CCc1ncc(-c2cn(-c3cc(C(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)ccc3C)nn2)[nH]1.COc1c(NC(=O)c2ccc(C)c(-n3cc(-c4cnn(C(C)C)c4C(C)C)nn3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4031614 0.92 BRAF (0.46) BRAF
SCHEMBL4034915 0.92 BRAF (0.47) BRAF
Hydrochloric Acid SCHEMBL4034747 0.91 BRAF (0.46) BRAF
SCHEMBL4032448 0.87 BRAF (0.45) BRAF
SCHEMBL4036624 0.86 BRAF (0.47) BRAF
SCHEMBL302551 0.83 BRAF (0.47) BRAF
SCHEMBL4034309 0.82 BRAF (0.49) BRAF
SCHEMBL4031982 0.82 BRAF (0.43) BRAF
SCHEMBL4032046 0.80 BRAF (0.47) BRAF
SCHEMBL13848724 0.80 BRAF (0.40) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4850824-B2 2012-01-11 JP claimed
EP-1725544-A1 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-11-29 EP claimed
WO-2005090333-A1 3-‘4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-09-29 WO claimed